Topical Tacrolimus for the Treatment of Atopic Dermatitis with Truncal Lesion
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ko, Hyun Chang | - |
dc.contributor.author | Kim, Woo Il | - |
dc.contributor.author | Cho, Sang Hyun | - |
dc.contributor.author | Park, Young Lip | - |
dc.contributor.author | Choi, Eung Ho | - |
dc.contributor.author | Son, San. Wook | - |
dc.contributor.author | Lew, Bark Lynn | - |
dc.contributor.author | Lee, Yang Won | - |
dc.contributor.author | Seo, Young Jun | - |
dc.contributor.author | Kim, Gyong Moon | - |
dc.contributor.author | Min, Joon Hong | - |
dc.contributor.author | Na, Chan Ho | - |
dc.contributor.author | Won, Chong Hyun | - |
dc.contributor.author | Shin, Hyoseung | - |
dc.contributor.author | Lee, Kwang Hoon | - |
dc.contributor.author | Roh, Joo Young | - |
dc.contributor.author | Park, Young Min | - |
dc.contributor.author | Jang, Yong Hyun | - |
dc.contributor.author | Yun, Seok Kweon | - |
dc.contributor.author | Kim, You Chan | - |
dc.contributor.author | Park, Gyeong Hun | - |
dc.contributor.author | Park, Chun Wook | - |
dc.date.accessioned | 2021-09-02T12:47:44Z | - |
dc.date.available | 2021-09-02T12:47:44Z | - |
dc.date.created | 2021-06-16 | - |
dc.date.issued | 2018-04 | - |
dc.identifier.issn | 1013-9087 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/76191 | - |
dc.description.abstract | Background: Topical tacrolimus is an effective anti-inflammatory therapy for acute and chronic states of atopic dermatitis (AD) in both adults and children. Topical tacrolimus has particular use at sensitive areas such as the face, anogenitals, and skin folds of neck and extremities. However, many AD patients also experience aggravated symptoms on trunk. Objective: The aim of this study was to investigate the efficacy and safety of topical tacrolimus for AD patients with truncal lesions. Methods: AD patients with truncal lesions who were aged >= 2 years were recruited from 20 centres in Korea. They received treatment with topical tacrolimus ointment twice daily during 4 weeks. The primary end point was change of the local eczema area and severity index (EASI) of the trunk from baseline to day 28. The secondary end points were changes in the patient global assessment (PGA) score and itch visual analogue scale (VAS) score of the trunk between baseline and day 28. Results: Two hundred and ninety-one patients were recruited, and 176 patients completed the full 4-week treatment course. By the end of the treatment, the mean local EASI of the trunk (2.2 +/- 4.71) was significantly decreased from that at baseline (4.71 +/- 4.03, p< 0.001). PGA (1.71 +/- 1.15) and itch VAS score of the trunk (2.61 +/- 2.19) on day 28 were also profoundly decreased compared with the baseline (2.96 +/- 1.07 and 5.15 +/- 2.47, respectively). No serious adverse events were observed during the study period. Conclusion: Topical tacrolimus is an effective and safe therapy for truncal lesions in AD patients. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | KOREAN DERMATOLOGICAL ASSOC | - |
dc.subject | PROACTIVE TREATMENT | - |
dc.subject | ADULTS | - |
dc.subject | CORTICOSTEROIDS | - |
dc.subject | INTOLERANT | - |
dc.subject | MANAGEMENT | - |
dc.subject | EFFICACY | - |
dc.subject | OINTMENT | - |
dc.subject | CHILDREN | - |
dc.subject | THERAPY | - |
dc.title | Topical Tacrolimus for the Treatment of Atopic Dermatitis with Truncal Lesion | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Son, San. Wook | - |
dc.identifier.doi | 10.5021/ad.2018.30.2.173 | - |
dc.identifier.scopusid | 2-s2.0-85043291038 | - |
dc.identifier.wosid | 000433992100007 | - |
dc.identifier.bibliographicCitation | ANNALS OF DERMATOLOGY, v.30, no.2, pp.173 - 178 | - |
dc.relation.isPartOf | ANNALS OF DERMATOLOGY | - |
dc.citation.title | ANNALS OF DERMATOLOGY | - |
dc.citation.volume | 30 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 173 | - |
dc.citation.endPage | 178 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART002333031 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Dermatology | - |
dc.relation.journalWebOfScienceCategory | Dermatology | - |
dc.subject.keywordPlus | PROACTIVE TREATMENT | - |
dc.subject.keywordPlus | ADULTS | - |
dc.subject.keywordPlus | CORTICOSTEROIDS | - |
dc.subject.keywordPlus | INTOLERANT | - |
dc.subject.keywordPlus | MANAGEMENT | - |
dc.subject.keywordPlus | EFFICACY | - |
dc.subject.keywordPlus | OINTMENT | - |
dc.subject.keywordPlus | CHILDREN | - |
dc.subject.keywordPlus | THERAPY | - |
dc.subject.keywordAuthor | Atopic dermatitis | - |
dc.subject.keywordAuthor | Tacrolimus | - |
dc.subject.keywordAuthor | Topical administration | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.